Naomi Rifaela

Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors

Paul van der Leest, Birgitta I. Hiddinga, Anneke Miedema et al. · Molecular Oncology · 2021 · 46 citations · Full text

Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study

Pierre‐Jean Lamy, Paul van der Leest, Nicolas Lozano et al. · Cancers · 2020 · 31 citations · Full text

Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling

Paul van der Leest, Emma M Ketelaar, Carel J.M. van Noesel et al. · Clinical Chemistry · 2022 · 21 citations · Full text

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients

Paul van der Leest, Melanie Janning, Naomi Rifaela et al. · International Journal of Molecular Sciences · 2023 · 17 citations · Full text

Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients

Paul van der Leest, Pim Rozendal, Naomi Rifaela et al. · Communications Medicine · 2025 · 11 citations · Full text